alexa The Key Roles & Responsibilities Of Pharmacists In Biosimilars Development
ISSN: 1948-593XX

Journal of Bioanalysis & Biomedicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference and Exhibition on Biowaivers, Biologics & Biosimilars
October 27-29, 2014 Hyderabad International Convention Centre, Hyderabad, India

N Srinivas
ScientificTracks Abstracts: J Bioanal Biomed
DOI: 10.4172/1948-593X.S1.013
Abstract
Biosimilars development is a landmine of complexities with respect to regulatory, manufacturing, marketing and pharmacovigilance aspects, making it one of the most expensive development propositions in the pharmaceutical industry. A typical development program of biosimilars includes analytical and bioanalytical assays, manufacturing, pharmacology and/ or toxicology studies in animals and clinical trials. A pharmacist plays a imperative role in ensuring quality assurance and regulatory compliance in the conduct of clinical trial and pharmacovigilance activities. A pharmacist plays an important role in making formulary decisions about Biosimilars, educating health care administrators, providers, legislators, policymakers, sponsors, and patients about these products. A vital role is warranted in the pharmacovigilance to detect, assess, and prevent adverse effects and other drug-related problems from biopharmaceuticals. The clinical pharmacist should take a leadership role in a multidisciplinary effort to evaluate biosimilars for use in the institution through the formulary process, an objective analysis of comparative data demonstrating the efficacy and safety (especially immunogenicity) of a biosimilar for specific patient populations treated at the institution is needed. The manufacturing pharmacist should be aware of the types of data required to establish biosimilarity and interchangeability. Today, pharmacist?s role is far more crucial in the wake of multifaceted challenges in the biosimilars industry.
Biography
N Srinivas has completed his PhD from JNT University Hyderabad in the area of bioanalysis & clinical pharmacokinetics. He is the Professor and Principal of Malla Reddy Institute of Pharmaceutical Sciences, Secunderabad and has a blend of 18 years teaching and 4 years industrial experience. His prior experience includes training of clinical research to life science students and industry professionals. He has 10 papers in reputed journals and has guided 20 post graduate projects. He is serving as Member in institutional ethics committees (IEC) of couple of reputed hospitals.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords